A Metastatic Parachordoma Case

Authors

  • Şener Cihan Department of Medical Oncology, Okmeydani Training and Research Hospital , Istanbul
  • Birsen Songül Cihan Department of Radiology, Okmeydani Training and Research Hospital , Istanbul
  • Ajlan Atasoy Department of Medical Oncology, Diyarbakir Training and Research Hospital, Diyarbakır
  • Fahriye Tugba Kös Department of Medical Oncology, Sütçü İmam University Medical Faculty, Kahramanmaraş
  • Nalan Akgül Babacan Department of Medical Oncology, Cumhuriyet University Medical Faculty, Sivas

Abstract

Parachordoma is a soft tissue tumor with a high risk of local recurrence. Despite the fact that parachordomas mostly have an indolent course, distant metastasis can be seen on rare occasion. We hereby report a case of a 28-year-old male who was initially diagnosed with parachordoma five years ago when he presented with a mass on his right shoulder. He suffered from local recurrence twice within the first two years after his surgery. Metastatic disease later presented itself with a mass in his left retro-orbital fossa. The patient underwent a partial surgical resection and the pathologic evaluation was reported as ‘’myoepithelial tumor metastasis’’. The patient’s systemic work up showed bilateral pulmonary metastatic nodules and metastasis in the right sacroiliac joint. After radiotherapy for the sacroiliac and left orbital mass, chemotherapy was initiated. The regimen consisted of ifosfamide, mesna and doxorubicin. Follow-up evaluation revealed a minimal decrease in size in the pulmonary nodules and the retro-orbital mass.  There was no 18-FDG uptake in the sacroiliac mass on PET-BT. In conclusion, surveillance carries importance due to the risk of metastasis for patients with parachordoma. Systemic chemotherapy consisting of doxorubicin and ifosfamide could be used successfully.

References

Laskowski J. Zarys onkologii. In: Pathology of tumors. Kolodziejska H, ed. PZWL, 1955;91–9.

Silverberg SG, DeLellis RA, Frable WJ et al. Silverberg’s Principles and Practice of Surgical Pathology and Cytopathology. 4th ed., Philadelphia, Churchill Livingstone, 2006; 395-6.

Hornick JL, Fletcher CD. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol 1997; 27:1183-96.

Guedes A, Barreto BG, Barreto LG et al. Metastatic parachordoma. J Cutan Pathol 2009; 36:270-3.

Dabska M. Parachordoma: a new clinicopathologic entity. Cancer 1977; 40:1586-92.

Fisher C, Miettinen M. Parachordoma: a clinicopathologic and immunohistochemical study of four cases of an unusual soft tissue neoplasm. Ann Diagn Pathol 1997; 1:3-10.

Miettinen M, Gannon FH, Lackman R. Chordomalike soft tissue sarcoma in the leg: a light and electron microscopic and immunohistochemical study. Ultrastruct Pathol. 1992;16:577–86.

Carstens PH. Chordoid tumor: a light, electron microscopic, and immunohistochemical study. Ultrastruct Pathol. 1995;19: 291–5.

Kinoshita G, Yasoshima H. Case report: fatal parachordoma. J Orthop Sci. 2007;12:101–6.

Abe S, Imamura T, Harasawa A et al. Parachordoma with multiple metastases. J Comput Assist Tomogr. 2003;27:634–8.

Lococo F, Cesario A, Meacci E et al. Pulmonary Metastases From Parachordoma. The Annals of Thoracic Surgery 2009;88:9-10.

Antman K, Crowley J, Balcerzak SP et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 1993;11:1276-85.

Limon J, Babinska M, Denis A, Rys J, Niezabitowski A. Parachordoma: a rare sarcoma with clonal chromosomal changes. Cancer Genet Cytogenet. 1998;102:78–80.

Yildirim M, Şahin H, Badem H, et al. Recurrent metastasis of progressive parachordoma of spermatic duct to different sites in a year: A rare case. J Clin Exp Invest 2013; 4: 377-9.

Downloads

Published

27.06.2014